ARC Group Supports the “Lighting the Way to Cervical Cancer Elimination” Initiative at Kuala Lumpur Charity Event

ARC Group Supports the “Lighting the Way to Cervical Cancer Elimination” Initiative at Kuala Lumpur Charity Event

ARC Group is proud to have contributed to the in Lighting the Way to Cervical Cancer Elimination, an inaugural charity event held on 17 November 2025 at EQ Sky 51 in Kuala Lumpur. The initiative marked the world’s first official World Cervical Cancer Elimination Day, established by the 78th World Health Assembly as a global commitment to ending cervical cancer.

Hosted by Teal Asia, the event brought together partners, healthcare advocates, and supporters to raise awareness of cervical cancer prevention and to spotlight efforts across Malaysia to empower women through accessible HPV screening and community care.

During the evening, attendees witnessed Malaysia joining the world in illuminating landmarks in teal, the international colour for cervical cancer elimination, symbolizing unity, hope, and collective action.

A key highlight of the initiative was the recognition of Selina Yeop Junior, a strategic partner to ARC Group  and cervical cancer survivor who was nominated by the Gates Foundation for her advocacy work. Her efforts have helped mobilize support for awareness, screening access, and early detection across the region.

The event also supported the ROSE Foundation, a non-profit organization dedicated to eliminating cervical cancer in Malaysia through HPV self-sampling and impactful community outreach.

ARC Group was honoured to stand alongside organizations driving positive social impact, reinforcing our commitment to supporting meaningful causes and community health initiatives across the region.

About ARC Group

ARC Group is a global investment banking and advisory firm providing M&A advisory, capital markets, and strategic financial solutions to businesses worldwide. With a strong presence across Asia, Europe, and the United States, ARC Group has built a robust track record in cross border M&A, supporting emerging growth companies, mid-market leaders, and multinational corporates in navigating complex transactions and unlocking long term value.

For more information or any questions, please contact:

Anna Sahlberg Carlsson
Marketing Manager
[email protected]

Lighting the Way to Cervical Cancer Elimination Initiative, Kuala Lumpur Charity Event

Lighting the Way to Cervical Cancer Elimination Initiative, Kuala Lumpur Charity Event

Lighting the Way to Cervical Cancer Elimination Initiative, Kuala Lumpur Charity Event

Lighting the Way to Cervical Cancer Elimination Initiative, Kuala Lumpur Charity Event

Continue reading

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

HONG KONG, 18 June 2026 — ARC Group today announced that it has committed to invest in Cloudbreak Pharma Inc. (HKEX: 2592), a clinical-stage ophthalmology biotechnology company with operations across the United States and China, following the signing of a share subscription agreement through its wholly owned subsidiary ARC Group International Limited. The transaction marks […]
Rising Together | ARC Dragon Boat Team Takes to the Water
Bio Green Med Solution, Inc. Announces Business Combination Agreement to Acquire Future NRG Sdn. Bhd.
Inside ARC Group | University of Nottingham Ningbo China

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission